Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ibuprofen for the Prevention of Patent Ductus Arteriosus in Preterm And/or Low Birth Weight Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438002/all/repview. Accessed 30 April 2024.
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438002/all/repview. Accessed April 30, 2024.
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438002/all/repview
Ibuprofen for the Prevention of Patent Ductus Arteriosus in Preterm And/or Low Birth Weight Infants [Internet]. In: Cochrane Abstracts. [cited 2024 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438002/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
ID - 438002
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438002/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -